Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1548247/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832576221083336704 |
|---|---|
| author | Chengcheng Zhang Linling Wang Qianzhen Zhang Junjie Shen Xia Huang Meiling Wang Yi Huang Jun Chen Yanmin Xu Wenxu Zhao Yanan Qi Yunyan Li Yanjiao Ou Zhi Yang Cheng Qian |
| author_facet | Chengcheng Zhang Linling Wang Qianzhen Zhang Junjie Shen Xia Huang Meiling Wang Yi Huang Jun Chen Yanmin Xu Wenxu Zhao Yanan Qi Yunyan Li Yanjiao Ou Zhi Yang Cheng Qian |
| author_sort | Chengcheng Zhang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a7be0d4ae70d43a9adf48796b1bed6dc |
| institution | Kabale University |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-a7be0d4ae70d43a9adf48796b1bed6dc2025-01-31T09:46:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011610.3389/fimmu.2025.15482471548247Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinomaChengcheng Zhang0Linling Wang1Qianzhen Zhang2Junjie Shen3Xia Huang4Meiling Wang5Yi Huang6Jun Chen7Yanmin Xu8Wenxu Zhao9Yanan Qi10Yunyan Li11Yanjiao Ou12Zhi Yang13Cheng Qian14Department of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaDepartment of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, ChinaChongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd., Chongqing, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1548247/fullchimeric antigen receptor T cellscarcinoembryonic antigensingle-chain fragment variableaffinitycell therapy |
| spellingShingle | Chengcheng Zhang Linling Wang Qianzhen Zhang Junjie Shen Xia Huang Meiling Wang Yi Huang Jun Chen Yanmin Xu Wenxu Zhao Yanan Qi Yunyan Li Yanjiao Ou Zhi Yang Cheng Qian Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma Frontiers in Immunology chimeric antigen receptor T cells carcinoembryonic antigen single-chain fragment variable affinity cell therapy |
| title | Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma |
| title_full | Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma |
| title_fullStr | Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma |
| title_full_unstemmed | Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma |
| title_short | Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma |
| title_sort | corrigendum screening and characterization of the scfv for chimeric antigen receptor t cells targeting cea positive carcinoma |
| topic | chimeric antigen receptor T cells carcinoembryonic antigen single-chain fragment variable affinity cell therapy |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1548247/full |
| work_keys_str_mv | AT chengchengzhang corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT linlingwang corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT qianzhenzhang corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT junjieshen corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT xiahuang corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT meilingwang corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT yihuang corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT junchen corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT yanminxu corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT wenxuzhao corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT yananqi corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT yunyanli corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT yanjiaoou corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT zhiyang corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma AT chengqian corrigendumscreeningandcharacterizationofthescfvforchimericantigenreceptortcellstargetingceapositivecarcinoma |